Cigna Group (NYSE:CI) Stock Rating Lowered by Barclays

Cigna Group (NYSE:CI) was downgraded by equities research analysts at Barclays from an “overweight” rating to an “equal weight” rating in a research note issued on Tuesday. They currently have a $304.00 price target on the health services provider’s stock. Barclays‘s target price would indicate a potential upside of 6.27% from the stock’s current price.

Several other equities analysts have also weighed in on CI. Robert W. Baird set a $337.00 price objective on shares of Cigna Group in a research report on Friday, May 1st. Piper Sandler dropped their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Morgan Stanley increased their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. The Goldman Sachs Group increased their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Finally, Sanford C. Bernstein raised their price target on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 5th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $339.50.

Cigna Group Price Performance

Shares of CI opened at $286.06 on Tuesday. The firm has a market capitalization of $75.67 billion, a PE ratio of 12.13, a PEG ratio of 1.00 and a beta of 0.30. The company’s 50-day moving average is $277.02 and its 200-day moving average is $276.37. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts forecast that Cigna Group will post 30.39 EPS for the current year.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 205,904 shares of company stock valued at $60,277,068 in the last ninety days. 0.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Cigna Group

Several hedge funds have recently bought and sold shares of CI. Wilkerson Advisory Group LLC bought a new position in Cigna Group in the 4th quarter valued at about $25,000. Beacon Financial Strategies CORP bought a new position in Cigna Group in the 4th quarter valued at about $28,000. Cedar Mountain Advisors LLC increased its holdings in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after buying an additional 68 shares during the period. Kemnay Advisory Services Inc. bought a new position in Cigna Group in the 4th quarter valued at about $29,000. Finally, Prosperity Bancshares Inc bought a new stake in shares of Cigna Group during the 4th quarter valued at approximately $29,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.